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ABSTRACT
A challenge for large-scale siRNA loss-of-function
studies is the biological pleiotropy resulting from
multiple modes of action of siRNA reagents. A ma-
jor confounding feature of these reagents is the
microRNA-like translational quelling resulting from
short regions of oligonucleotide complementarity
to many different messenger RNAs. We developed
a computational approach, deconvolution analysis
of RNAi screening data, for automated quantita-
tion of off-target effects in RNAi screening data
sets. Substantial reduction of off-target rates was
experimentally validated in five distinct biological
screens across different genome-wide siRNA li-
braries. A public-access graphical-user-interface has
been constructed to facilitate application of this al-
gorithm.
INTRODUCTION
Genome-wide high-throughput RNA interference (RNAi)
screening has been widely applied in biomedical research
for discovery of drug targets or illumination of unknown
molecular machinery, and has proven to be an effective
means for functional annotation of protein-coding genes in
both normal and disease contexts (1–5). However, a press-
ing challenge for these studies is maximizing the return of
accurate gene-level information with a technique that is as-
sociated with pleiotropic mechanisms of action. For ex-
ample, multiple studies indicate that individual small in-
terfering RNAs (siRNAs) often interfere with the expres-
sion of hundreds of genes through partial sequence comple-
mentarity that imitates microRNA (miRNA) activity (6,7).
Therefore, the phenotypic read-outs from siRNA screens
are usually comprised of both the desired ‘on-target’ effects
of intended target gene depletion together with uninten-
tional ‘off-target’ effects that are oligonucleotide sequence
dependent, but target gene-independent. The latter can lead
to many false positive ‘hits’ that subsequently obscure in-
terpretation of the overarching screen results. Time- and
resource-intensive experimental approaches for target val-
idation therefore often define the limits of the reliable gene-
level information from any given screen. Computational ap-
proaches have been designed which can help identify off-
targeted transcripts within a given screening effort, and
therefore lead to the discovery of new genes or pathways as-
sociatedwith the phenotype under investigation (8,9). How-
ever, directly addressing high false positive rates and decon-
volution of off-target phenomena is still a major bottleneck
restraining the pace of discovery for functional genomics ef-
forts. To address this issue, we developed a computational
approach, Deconvolution Analysis of RNAi screening data
(DecoRNAi), for automated quantitation of off-target ef-
fects in RNAi screening data sets.
MATERIALS AND METHODS
Data processing
DecoRNAi approach has been tested in five distinct biolog-
ical screens across different genome-wide siRNA libraries,
and all data processing and Z score derivations were con-
sistent with the original publications (1–5).
(1) For the H1155 toxicity screens (1), host modulators of
H1N1-cytopathogenicity (3) and the HCC4017 toxic-
ity screens (5), raw cell viability data were transformed
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to robust Z score (formula shown below) and adjusted
for batch effect. That is, raw data were grouped by ex-
perimental batch and within each group, sample me-
dian and median absolute deviation were used to calcu-
late robust Z score. Annotation of all siRNA/miRNAs
pools and their associatedZ scores can be found in Sup-
plementary Tables S1, S2, S3 and S6.
Z= cell viability − sample median
median absolute deviation (MAD)
MAD = mediani (|Xi − sample median|)
(2) For the WNT (int/Wingless) pathway siRNA screen
(4), Z scores were calculated as a standard score cen-
tered on the population mean of each screening run as
described by the average of each triplicate experiment
minus the standard deviation. Annotation of all siRNA
pools and their associatedZ scores can be found in Sup-
plementary Table S4.
(3) For the selective autophagy siRNA screen (2), mi-
tochondrial mass for each cell was approximated by
the following formula: mitochondrial mass ∼ β0 + β1
Parkin + β2 siRNA + 3 Parkin × siRNA. Two-way
ANOVA models were used to identify siRNAs that de-
creased Parkin-mediated mitophagy and Z scores were
calculated as the statistical significance. Annotation of
all siRNA pools and their associated Z scores can be
found in Supplementary Table S5.
DecoRNAi analysis
The LASSO (least absolute shrinkage and selection op-
erator) regression approach was adapted to quantify the
strength of seed-link effects. For this analysis, each Z score
is modeled as a linear combination of on-target effect
(demonstrated in the Supplementary Figure S5) and seed
sequence based off-target effects. The LASSO regression
model was defined as below:
Z= X β + Y, subject to | β| < s
where Zi is the ith original Z score, β j is the estimated off-
target effect of the jth seed family,Yi is the correctedZ score
(on-target effect) and λ is the penalty parameter. X is de-
noted as below:
X = [xi j ] , xi j =
{
1, if i ∈ j th family
0, otherwise
And the solution is given:
βˆ = argmin
β
[
|| Z− X β||2 + λ| β|
]
For each seed family, we can thus estimate the coefficient
that indicates the strength and direction of predicted off-
target effects. A negative coefficient means the seed family
tends to lower Z scores and vice versa. Based on empiri-
cal experience, λ is set to 0.001 as the default. We annotate
those coefficients with absolute value >1 as indicating can-
didate off-target effects for all four datasets shown in this
manuscript. However, all the parameters and cutoff values
are tunable by users.
For LASSO-selected off-target seed families, we further
examine the statistical significance using the Kolmogorov-
Smirnov test (KS-test). Taking Z as a vector of original Z
scores from primary screening, the empirical distribution
function Fn for Z scores from seed family S is defined as:
Fns (z) =
1
Ns
Ns∑
i=1
IZi≤z
where IZi≤z is the indicator function, equal to 1 if Zi ≤ z
and equal to 0 otherwise,Ns is the total number of Z scores
from seed family S. The KS statistic for a given cumulative
distribution function F(z) is as:
Dns = sup
z
|Fns (z) − F(z)|
The statistical significance (P-value) was then determined
by the KS statistic.
Web-based application (Galaxy)
The DecoRNAi application is available at http://galaxy.
qbrc.org/root?tool id=sirna offtarget, which is an open
web-based interface. Analysis parameters can be specified
by users as below:
 InputFile: CSV File containing response variable and
siRNA sequence data.
 Strand: Specify the strand orientation for analysis.
 Lambda: Penalty parameter used in the model.
 Seed: Range: 1–14. Specify the seed region to be used.
 Library: Specify siRNA library. Default is custom which
requires user input sequences.
 Strength: Specify the cutoff for strength of seed-linked
effect. Must be positive value.
 Significance: Specify the cutoff for significance (P-value).
Tissue culture, oligo transfection and cell viability assays
In primary screening, all projects employed pooled siRNAs
targeting strategy. The sequences of pooled siRNAs are dif-
ferent. However, by design, the siRNAs within the same
pool should be targeting the same gene by perfectly match-
ing on different location of the corresponding messenger
RNAs (mRNAs) (Supplementary Figure S5).
In secondary individual oligo screening, H1155 cells
were grown in RPMI 1640 (Gibco R©) supplemented with
5% fetal bovine serum (FBS; Atlanta Biologicals) and 1%
penicillin/streptomycin (Gibco R©). All siRNAs were pur-
chased from Dharmacon. The library contains 24 sets of
four siRNAs each. The oligos targeting transmembrane
protein 114 (TMEM114) from Dharmacon were used for
siRNAnegative control. ThemiR 4633-5p and the synthetic
miRNA were from Ambion. Nontargeting miRNA con-
trol (IN-001005-01-05) was from Dharmacon. For reverse
transfection, 1 l siRNA (10uM) in 30 l serum free media
(SFM) was mixed with 0.4 l RNAiMax (Invitrogen) in 10
l SFM. 40 l siRNA-reagent mix per well and 5000 cells
per well, from a single cell suspension, were delivered in 100
l media in 96-well microtiter plates. Cell viability was mea-
sured 96 h post-transfection with CellTiter-Glo (Promega)
according to manufacturer’s specifications.
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Figure 1. Deconvolution analysis of RNAi screening data (DecoRNAi). (a) Workflow of DecoRNAi analysis. (b) Original phenotypic measurements (Z
scores, etc.) are projected on both on-target effect (green) and off-target effect (red) in a deconvolution pattern (top panel). A penalized linear model is
used to quantify on-target and off-target effects. The resulting seed family scores from a genome-wide H1155 siRNA toxicity screen are shown (bottom
panel). Each dot represents a seed family including all siRNAs sharing the same seed sequence. X-axis is estimated strength of seed-linked effect (off-target
effect) and Y-axis is P value associated with each seed family.
RESULTS
Here we have designed a data-driven computational ap-
proach,DecoRNAi, to quantify and correctmiRNA-mimic
off-target effects from whole-genome RNAi screens (Fig-
ure 1a). DecoRNAi simultaneously estimates gene-level on-
target effects and siRNA oligonucleotide-level off-targets
effects based on deconvolution of phenotypic measure-
ments fromprimary screening data (Figure 1b). Experimen-
tal evaluation, using thousands of oligonucleotide retests
across five independent whole-genome siRNA screens, indi-
cated miRNAmimicry by siRNA oligonucleotides is a per-
vasive source of ‘off-target’ biological responses to siRNA.
Application of DecoRNAi significantly enhanced the fi-
delity of single gene-level observations at whole-genome
scale, and is provided here an open-source tool to en-
hance lead discovery accuracy from high-throughput RNAi
screening studies.
A major determinant of the mRNA targets for trans-
lational suppression by a given miRNA, is partial
mRNA/miRNA complementarity corresponding to a
6-nucleotide ‘seed sequence’ on the 5′ end of the miRNA
(10). By this definition, there is a sum total of 46 (4096)
possible non redundant ‘seed sequences’ within any siRNA
or small hairpin RNA (shRNA) library collection. As
there are usually tens to hundreds of thousands of oligos
in a given screening collection, the presence of a given
seed sequence within many different siRNA/shRNA
reagents presents the opportunity to identify ‘seed-driven’
phenotypic associations among reagents within a given
screen. To begin to test this, we examined a whole-genome
siRNA toxicity screen in H1155 non-small cell lung cancer
cells (3) (Supplementary Table S1) as a benchmark for
identification of a reasonable scoring approach. This is a
cell-based high-throughput RNAi screen to identify genes
required for lung cancer cell viability. This screen employed
an arrayed one-gene/one-well commercial siRNA library
with pools of four independent siRNA oligonucleotide
duplexes per gene. Seed sequence membership for each of
the 168 992 oligonucleotides in the library was separately
defined for each of the 6-mer windows present within each
19-mer (Supplementary Figure S1a). The toxicity value
for each siRNA pool was calculated as a Z score from
a triplicate analysis in order to control for position and
batch effects (11). We employed a two-sample KS-test as a
nonparametric method to discover oligonucleotide-specific
effects based on the coherent behavior of groups of siRNA
pools with oligos sharing a common seed sequence (Sup-
plementary Figure S1b). Using a confidence threshold of a
false discovery rate (FDR) of 5%, seed family/phenotype
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on D
ecem
ber 10, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2014, Vol. 42, No. 13 8217
Figure 2. Experimental evaluation of seed-effect predictions. (a) Density
distributions of consequences on cell viability (X-axis) of siRNA duplexes
containing predicted off-target seed sequences (red curve) versus siRNA
duplexes targeting the same genes but without predicted off-target seed se-
quences (green curve). (b) Cell viability in response to individual siRNA
oligo duplexes from 24 gene pools tested in H1155 cells. Red dots indicate
duplexes with an oligonucleotide containing the candidate off-target seed
sequence. Green dots represent siRNA duplexes, designed to target the
same gene, which do not contain the candidate off-target seed sequence. (c)
An oligonucleotide mimic of hsa-miR-4633 significantly inhibited H1155
cell viability. Hsa-miR-4633 contains the seed sequence UAUGCC that
was identified as an off-target seed through DecoRNAi analysis. (d) A
synthetic miRNA mimic designed using the predicted off-target seed GU-
UCCG significantly inhibited H1155 cell viability, while a control miRNA
mimic of identical sequence with the exception of the indicated seed region
did not.
associations were detected only within seed families defined
by positions 1–6, 2–7 and 3–8 (Supplementary Figure
S1c). The majority corresponded to a seed definition of
nucleotides 2–7, in keeping with current best estimations of
dominant determinants of miRNA target specificity (10).
Using that definition for seed family membership, there are
4001 unique seed sequences represented among the 168 992
Dharmacon oligonucleotides, with a median frequency of
representation of 27 siRNA pools (Supplementary Figure
S1d). A liability of the KS-test is sensitivity to family size.
This can result in the discovery of associations with very
low P-values but very small effect sizes (Supplementary
Figure S1e–g). To defend against that, we developed
DecoRNAi algorithm that estimated strength and direc-
tion of seed-driven effects using LASSO as a penalized
regression model (see ‘Materials and Methods’ section).
Application of DecoRNAi to the H1155 toxicity screen
identified 13 potential seed-driven phenotypic associations
corresponding to 365 siRNA pools (Supplementary Fig-
ure S2a). For experimental evaluation of candidate seed-
driven effects, we chose four ‘off-target’ seed families (GU-
UCCG, UCCAGG, UUGCAG, UAUGCC) for a focused
secondary screen (Supplementary Figure S2c–f). Twenty-
four genes were selected and for each gene, the correspond-
ing Dharmacon siRNA pool was retested as four individ-
ual siRNAs for consequences on H1155 cell viability. Of
note, siRNA duplexes containing an oligo with the detected
off-target seed sequence were consistently associated with
stronger consequences on cell viability than the remaining
siRNA duplexes designed to target the same gene (Figure
2a, b, Supplementary Figure S2g). Consistent with this, the
cumulative density function indicates a significant shift in
theZ scores associatedwith predicted seed-driven off-target
effects (Supplementary Figure S2b, P = 4.56 × 10−13).
Of the detected seed families, only one (UAUGCC) is
present within the seed sequence of an annotated human
miRNA (hsa-miR-4633-5p). As expected, introduction of
the miRNA mimic corresponding to miR-4633-5p resulted
in a similar viability defect (Figure 2c). To further test the
sufficiency of seed sequence identity for induction of off-
target phenotypes, we engineered a synthetic miRNA cor-
responding to the validated seed family GUUCCG (Sup-
plemental Figure S2c, g). This reagent also effectively in-
hibited viability of H1155 cells, consistent with a dominant
seed-sequence dependent mode of action (Figure 2d).
We next applied DecoRNAi to four additional whole-
genome siRNA screens employing distinct biological con-
texts and endpoint assays. These included a siRNA and
miRNA mimic screen for host modulators of H1N1-
cytopathogenicity, a siRNA screen for modulators ofWNT
reporter gene activation, a siRNA image-based screen for
selective autophagy factors and one additional screen for
lung cancer drug target discovery using a distinct whole-
genome siRNA library.
The H1N1-cytopathogenicity screen sought to return
genes that modulate influenza virus replication in human
bronchial epithelial cells (3) (Supplementary Tables S2
and S3). For the primary screen, synthetic interactions
of siRNAs and miRNA mimics with H1N1-induced cy-
topathogenicity were measured using cell viability as the
endpoint assay. From the siRNA screen, DecoRNAi identi-
fied 13 significant seed families corresponding to eight syn-
thetic lethal associations (353 siRNA pools) and five syn-
thetic viable associations (96 siRNA pools) (Supplemen-
tary Figure S3a). One of eight synthetic lethal associations
corresponded to a human miRNA; hsa-miR-491. Of note,
the hsa-miR-491 mimic was also the best scoring synthetic
lethal reagent from the miRNA mimic screen (Figure 3a).
The WNT screen sought to return genes modulating
WNT pathway activation, and thus employed a highly spe-
cific endpoint assay using a WNT-specific and a WNT-
independent reporter gene combination (4) (Supplementary
Table S4). Here, only one seed-sequence association was
identified among reagents that selectively inhibited WNT
reported activity (Supplementary Figure S3b). This may be
indicative of the narrower biological space that can inter-
sect the endpoint assay employed in this screening effort,
and which is therefore less exposed to perturbation by mul-
tiple seed-family oligonucleotides.
The autophagy screen is an image-based screen, at sin-
gle cell resolution, that sought to identify gene products re-
quired for virophagy by measuring colocalization of Sin-
bis virus capsid protein with autophagolysosomes (2) (Sup-
plementary Table S5). DecoRNAi detected six significant
seed-sequence associations with inhibition of selective au-
tophagy corresponding to 125 siRNA pools (Supplemen-
tary Figure S3c). From 28 individual siRNA oligo retests,
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Figure 3. Application ofDecoRNAi to additional RNAi screens with distinct biological contexts. (a) Identification and estimation of seed-sequence depen-
dent off-target effects from a genome-wide siRNA screen for modulators of H1N1 induced cell death in HBEC30 cells. Consequences of 426 MicroRNA
mimics on HBEC30 cell viability upon H1N1 infection are shown. hsa-miR-491, which contains a predicted off-target seed sequence, is as indicated. Out
of all miRNA mimics, hsa-miR-491 has the lowest cell viability. Annotation of all miRNA mimics and their associated viability scores can be found in
Supplemental Table S3. (b) Identification and estimation of seed-sequence dependent effects from a genome-wide siRNA screen for modulators of selective
autophagy in HeLa cells. Phenotypic Z scores from secondary screens of individual siRNA duplexes with and without predicted off-target seed sequences
are plotted as indicated. (c) DecoRNAi-mediated Z score corrections reduce false positive rates in autophagy modulator screen. Here, gene targets scoring
positive with two or more confirmed siRNAs out of a total of four are considered to be true positives. The X-axis indicates arbitrary ‘hit’ thresholds based
on rank-orderedZ scores and the Y-axis indicates the corresponding false positive rate. For example, the false positive rate for the top 20 ‘hits’ rank ordered
by Z score is 24% when using the primary Z score and 17% when using the corrected Z score. (d) Identification and estimation of seed-sequence dependent
off-target effect from a genome-wide siRNA toxicity screen on HCC4017 using an alternative distinct siRNA library. Individual oligos from three genes
in HCC4017 screen data were tested as indicated. Viability phenotypes were uncoupled with from target gene knock-down. Individual oligos from three
genes in HCC4017 screen data were tested. Target genes were knocked down by all siRNAs, however, only oligos with off-target seeds reduced cell viability.
those belonging to the detected off-target seed families
trended towards lower Z scores than those designed to tar-
get same genes but not belonging to the predicted off-target
seed families (Figure 3b). Importantly, substitution of the
originalZ scoreswithDecoRNAi-correctedZ scores, which
remove the estimated miRNA-like off-target effects from
the overall phenotypic measures (‘Materials and Meth-
ods’ section), significantly reduced the experimentally de-
termined false positive rate (Figure 3c).
To evaluate the performance of DecoRNAi using dif-
ferent genome-wide siRNA libraries, we examined addi-
tional toxicity screens designed to identify genes required
for lung cancer cell viability (5). The non-small cell lung
cancer cell line HCC4017 was screened for siRNA pools
from the Ambion ‘Silencer-Select’ library that significantly
impaired viability (Supplementary Table S6). DecoRNAi
identified 10 off-target seeds from the library enriched
in these screens (Supplementary Figure S3d). Testing of
60 individual siRNA oligonucleotides consistently showed
that siRNAs containing these ‘off-target’ seeds have dra-
matic consequences on cell viability as compared to other
siRNAs targeting the same genes (Figure 4a). For in-
dividual siRNA duplexes targeting SIAT7D, BZW2 and
DNAJA4 (Figure 4b), mRNA expression data showed that
all reagents successfully depleted the corresponding target
gene mRNA, however, only oligos containing the predicted
off-target seed had significant viability phenotypes (Figure
3d). miRNA and synthetic miRNA phenotypes were con-
sistent with a dominant seed-sequence dependent mode of
action (Figure 4b–d).
To facilitate application of the DecoRNAi algorithm, we
have released a public access web-based graphical user in-
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Figure 4. Application of DecoRNAi to a distinct siRNA library. (a) Identification and estimation of seed-sequence dependent effects from a genome-wide
siRNA toxicity screen in HCC4017 cells using an alternative siRNA library. Density distributions of consequences on cell viability (X-axis) of siRNA
duplexes containing predicted off-target seed sequences (red curve) versus siRNA duplexes targeting the same genes but without predicted off-target seed
sequences (green curve). (b) Identified off-target seed UCUGAC and ACAUGU were retested using individual oligos designed to target SIAT7D, BZW2
andDNAJA4.miRNAmimic and syntheticmiRNAwere also retested. (c) An oligonucleotidemimic of hsa-miR-4256 sharing seedUCUGAC significantly
inhibited HCC4017 cell viability. (d) A synthetic miRNA mimic designed using the predicted off-target seed ACAUGU significantly inhibited HCC4017
cell viability, while a control miRNA mimic of identical sequence with the exception of the indicated seed region did not.
terface http://galaxy.qbrc.org/root?tool id=sirna offtarget
for custom analysis (Figure 5). This tool contains pre-
computed seed sequence families for three commonly em-
ployed commercial siRNA libraries. For custom collec-
tions, the tool will compute seed sequence membership
from a user-supplied reagent sequence table. The default
parameters were provided for the DecoRNAi online tools
based on the empirical performance, but all the parame-
ters were tunable by users. The output files include global
data visualization, the identified seed family associations,
the siRNA pools containing off-target seed families, cor-
rected Z scores and the potential miRNAs with pheno-
types of interest (Figure 5, Supplementary User’s Man-
ual). To facilitate local software installation, we also de-
veloped an R package for user to perform custom analy-
sis available on our galaxy webpage http://galaxy.qbrc.org/
root?tool id=sirna offtarget.
DISCUSSION
We constructed DecoRNAi to quantify seed-driven off-
target activity by modeling the enrichment of oligonu-
cleotide sequence-specific effects from genome-wide RNAi
primary screen data. The approach does not require ar-
bitrary phenotypic threshold selection, and combines sta-
tistical significance of population separation with pheno-
typic effect size to return biologically meaningful corre-
lations. We have found that the algorithm performs well
across diverse phenotypic assays and within distinct reagent
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Figure 5. Illustrations of the web-based graphical user interface for DecoRNAi analysis. Seed families are pre-computed for the Dharmacon Library circa
2005, Dharmacon Library circa 2009 and Ambion Silencer Select. For screens employing these reagents, the only required input is the quantitative screen
measurement for each reagent (for example, normalized Z score). Other libraries can be analyzed upon uploading the library-wide sequence information
for each oligonucleotide or processed shRNA. Parameter settings are user-selected. The output files include global visualization of seed family behavior,
the predicted off-target seed families, the siRNA pools containing off-target seed families, the potential miRNAs sharing common seeds with identified
off-target seed families and the corrected Z scores (not shown here).
collections. As expected, miRNA-like behavior of siRNA
oligonucleotides was a pervasive feature associatedwith pri-
mary screening phenotypes. This was detectable by DecoR-
NAi, experimentally verifiable, and could be imitated with
appropriately designed synthetic miRNA-like molecules.
GESS (genome-wide enrichment of seed sequence
matches) is recently reported computational tool designed
to identify off-targeted transcripts rather than to isolate
and correct off-target phenotypes (8). We applied the GESS
algorithm in an attempt to employ it for the latter. However,
this method identified no off-target siRNA pools from
either the H1155 toxicity screen or the selective autophagy
screen. In stark contrast, this approach identified 23 807
off-target siRNA pools from the H1N1 cytopathogencity
screen (Figure 6a–c). However, we anticipate that GESS’s
intended utility will dovetail with DecoRNAi, providing
a mechanism to help identify gene cohorts that are re-
sponding to siRNAs responsible for seed-sequence driven
phenotypes.
Two additional computational efforts designed to de-
flect spurious gene-level annotations from large-scale RNAi
screens are ATARiS (Analytic Technique for Assessment of
RNAi by Similarity) (12) and CSA (Common Seed Analy-
sis) (13). ATARiS was developed to detect coherent behav-
ior from multiple shRNAs targeting the same gene. While
effective, the method is less generalizable outside of pooled
shRNA screens and requiresmulti-sampleRNAi screens (at
least 10 samples in their publication). CSA, likeDecoRNAi,
detects correlated biological behavior of siRNAs that share
the same seed sequence.However, CSAdoes not account for
family-size bias with its statistical significance metric. Inte-
gration of statistical significance with the strength and di-
rection of biological phenotypes is likely an important con-
sideration for optimized detection of false positives (Sup-
plementary Figure S4c–e). Furthermore, DecoRNAi quan-
tifies seed-driven off-target effects by modeling the on-
target effects and off-targets from all individual siRNA du-
plexes in the same gene pool, which is more efficient than
looking at individual siRNA seed families separately. In
support of these considerations, we found that the DecoR-
NAi corrected Z scores had a significantly better true posi-
tive rate than CSA corrections (Figure 6d).
A limitation of DecoRNAi is appropriate representa-
tion of seed families within a given screening collection
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Figure 6. Comparison with GESS and CSA analysis. GESS analysis of human mRNA 3′ UTRs from primary data of the H1155 toxicity screen (a), the
selective autophagy screen (b), and the H1N1 cytopathogencity screen (c). Each point represents one 3′ UTR and represents SMFa value plotted against
the SMFi value. (d) DecoRNAi-mediatedZ score corrections reduce false positive rates compared to CSA approach from selective autophagy screen. Here,
gene targets scoring positive with two or more confirmed siRNAs out of a total of four are considered to be true positives. The X-axis indicates arbitrary
‘hit’ thresholds based on rank-ordered Z scores after applying DecoRNAi approach or CSA approach, and the Y-axis indicates the corresponding false
positive rate.
to reach sufficient statistical power for detection of phe-
notypic associations. However, from the cumulative anal-
ysis of five different whole genome siRNA screens, we esti-
mate that the DecoRNAi approach will cover ∼85% of the
seed sequence families present in a typical commercial ar-
rayed siRNA library (Supplementary Figure S4a and b). To
facilitate automated application of DecoRNAi to siRNA
and shRNA library screening efforts, we have embedded
pre-computed seed family annotations for three commonly
used commercial RNAi libraries (Dharmacon Library circa
2005, Dharmacon Library circa 2009 and Ambion Si-
lencer). In addition, we proved a tool for automated gen-
eration of seed family annotation of user-specific siRNA or
shRNA oligonucleotide collections (http://galaxy.qbrc.org/
root?tool id=sirna offtarget). The tool is based on Galaxy
open source framework, accepts phenotypicmeasures (such
as Z scores) from primary screens as input, and allows iter-
ative parameter choices for data analyses. All of the user-
specified parameters are documented in detail, and the in-
termediate outputs are provided for transparent analysis
(Figure 5, Supplementary User’s Manual).
In summary, DecoRNAi is a computational tool that fills
an important unmet need for the functional genomics re-
search community as it enhances the return of rigorous bio-
logically meaningful observations downstream of screening
efforts that otherwise consume huge time and reagent re-
sources by following bad leads, or by weeding them out us-
ing strictly empirical approaches. Substantial reduction of
off-target rates was experimentally validated in five distinct
biological screens across different genome-wide siRNA li-
braries. A public-access graphical user interface has been
constructed to facilitate application of this algorithmby any
investigator.
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